Long-Term Investing in Emerging Markets.

Publikováno v: Wall Street Transcript. 2/16/2015, p46-50. 5p.

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).

Autor: Staffurth JN; Cardiff University/Velindre Cancer Centre, Cardiff, UK., Haviland JS; The Institute of Cancer Research, London, UK. Electronic address: jo.haviland@icr.ac.uk., Wilkins A; The Institute of Cancer Research, London, UK., Syndikus I; Clatterbridge Cancer Centre, Wirral, UK., Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK., Parker C; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Logue J; Christie Hospital, Manchester, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Malik Z; Clatterbridge Cancer Centre, Wirral, UK., Panades M; Lincoln County Hospital, Lincoln, UK., Eswar C; Clatterbridge Cancer Centre, Wirral, UK., Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Russell M; Beatson West of Scotland Cancer Centre, Glasgow, UK., Ferguson C; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., O'Sullivan JM; Queen's University Belfast, Belfast, UK., Cruickshank CA; The Institute of Cancer Research, London, UK., Dearnaley D; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Hall E; The Institute of Cancer Research, London, UK.

Publikováno v: European urology oncology [Eur Urol Oncol] 2021 Dec; Vol. 4 (6), pp. 980-992. Date of Electronic Publication: 2021 Sep 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.

Autor: Fenwick JD; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Landau DB; Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address: dblandau@gmail.com., Baker AT; Oxford Cancer Centre, Oxford, United Kingdom., Bates AT; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Eswar C; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom., Garcia-Alonso A; North Wales Cancer Treatment Centre, Rhyl, United Kingdom., Harden SV; Addenbrookes Hospital, Cambridge, United Kingdom., Illsley MC; Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom., Laurence V; Poole Hospital NHS Foundation Trust, Poole, United Kingdom., Malik Z; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom., Mayles WPM; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom., Miles E; Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Middlesex, United Kingdom., Mohammed N; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Spicer J; Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom., Wells P; Barts Health NHS Trust, London, United Kingdom., Vivekanandan S; Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom., Mullin AM; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Hughes L; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Farrelly L; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Ngai Y; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Counsell N; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 15; Vol. 106 (4), pp. 733-742. Date of Electronic Publication: 2019 Dec 03.

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer

Autor: Lester, J, Nixon, L, Mayles, P, Mayles, H, Tsang, Y, Ionescu, A, Courtier, N, Nahum, A, Fenwick, J, Eswar, C, Malik, Z, Mohammed, N, Griffiths, G

Publikováno v: LUNG CANCER. 75

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2c438774db8c156a67be6746b4b899d4
http://ora.ox.ac.uk/objects/uuid:50a6ecc7-8ac4-483a-b091-3bc700252438